Home | Free 14-Day Trial | Tutorial | Help
Medical Disability Advisor  >  Adhesive Capsulitis Of Shoulder  see more: ACOEM - Shoulder Disorders

Adhesive Capsulitis of Shoulder


Related Terms


  • Frozen Shoulder
  • Periarthritis

Specialists


  • Occupational Therapist
  • Orthopedic (Orthopaedic) Surgeon
  • Physiatrist
  • Physical Therapist
  • Rheumatologist
  • Sports Medicine Internist

Comorbid Conditions


Sign-in as a subscriber or take a free trial to see the renowned Reed Group physiological recovery durations in place of this advertising.

Factors Influencing Duration


The presence of comorbid conditions usually prolongs disease and disability duration. Improper or delayed treatment or aggressive surgical treatment may contribute to delayed recovery. Work absence will likely be greater if the dominant shoulder is affected and/or the occupation requires lifting, carrying, and overhead work. If the nondominant side is involved or the individual is employed in sedentary or light work, earlier resumption of employment would be anticipated. If surgery is required for adhesive capsulitis or a comorbid condition, additional therapy of perhaps 6 to 12 weeks in duration will be necessary, further delaying return to work and other functions.

Medical Codes


ICD-9-CM:
726 - Peripheral Enthesopathies and Allied Syndromes
726.0 - Adhesive Capsulitis of Shoulder

Definition


© Reed Group
Adhesive capsulitis is a condition of the shoulder characterized by stiffness, loss of motion (contracture), and pain. Often called frozen shoulder, adhesive capsulitis is clinically divided into two classes, primary and secondary. Individuals with primary adhesive capsulitis, which is characterized by a significant limitation of both active and passive motions of the shoulder, can recall no possible cause of the condition (idiopathic adhesive capsulitis). Individuals with secondary adhesive capsulitis are able to describe trauma or a possible cause prior to the onset of symptoms, such as fracture of the humerus, rotator cuff repair, shoulder girdle injury/surgery, or prolonged immobilization (e.g., holding an arm at the side while a broken wrist is healing).

Primary adhesive capsulitis generally undergoes three phases of variable duration. The first phase, a painful period lasting 2 to 9 months, begins with increased blood flow within the glenohumeral joint (shoulder joint between the humerus or upper arm bone and the glenoid or socket in the scapula). This frequently is associated with inflammation of the joint capsule and an insidious onset of pain. Pain may be aggravated by psychological stress and exposure to cold or vibration. The second is the adhesive, stiffening, or freezing phase lasting 4 to 12 months. The glenohumeral joint capsule undergoes fibrosis (scarring) and gradually shrinks, thereby progressively restricting joint motion. The third phase involves recovery or thawing and is of variable duration, lasting from several months to 3 years.

Primary adhesive capsulitis has been shown to be associated with autonomic dysfunction, genetic predisposition, or forgotten or unrecognized trauma. Other associated conditions include autoimmune, cerebrovascular, coronary artery, and cervical disc disease, as well as depression, hypothyroidism, and Parkinson's disease. It usually is not associated with osteoarthritis, rotator cuff injury, or malignancies. Although a specific trauma may not be identified, combined movements (abduction and external rotation) of the shoulder as in reaching overhead or reaching for a back pocket or dress zipper can sometimes cause the condition. The non-dominant shoulder is more often involved than the dominant one but the condition can affect both shoulders (bilateral) either sequentially or simultaneously in up to 16% of individuals (Roy). The occurrence of both unilateral and bilateral adhesive capsulitis is more common in individuals with diabetes.

Genetic abnormalities have been found to be associated with frozen shoulder, including the presence of specific genes in tissue samples obtained during surgery for the condition (Roy). Conditions that have been suggested to predispose individuals to primary and secondary adhesive capsulitis are trauma, surgery to the shoulder and/or other regions of the body, shoulder conditions that demonstrate similar restricted motion to that of adhesive capsulitis (e.g., bursitis, tendonitis), inflammatory diseases, diabetes, especially type 1 diabetes, hyperthyroidism, and dyslipidemia. Precisely why pain precedes stiffening and loss of motion is unclear, leading to the belief that the condition does not stem solely from mechanical defects within the glenohumeral joint itself. Neurologic factors may contribute to the generation of pain (e.g., sympathetic autonomic hyperactivity, alpha-adrenoreceptor hyper-responsiveness, and central nervous system factors). Inadequate blood supply (ischemia) to soft tissue identical to that found in Dupuytren’s contracture is also found in adhesive capsulitis, indicating a possible microvascular connection between neurologically mediated pain and connective tissue contracture, as well as a link between frozen shoulder and the microvascular aspects of diabetes.

Risk: Age increases risk, with most cases of FS occurring during the fifth and sixth decades of life; average age of onset is 52 years in women and 55 years in men (Roy). The condition occurs more frequently in women than in men (M-F ratio is 1.4:1) (Roy).

Incidence and Prevalence: Prevalence of adhesive capsulitis is reported to be 2% in the general population, increasing to 11% among diabetics. Incidence is even higher among those with type 1 diabetes. These individuals have a 40% lifetime chance of developing the disorder (Roy).

Source: Medical Disability Advisor



History


History: The individual usually reports a gradual onset that begins with pain followed by progressive stiffness. Sometimes, however, loss of motion may be the first complaint. Discomfort is often vague, but is typically worse at night, especially when the individual lies on the affected side. Pain usually is present with shoulder movement, prompting the individual to immobilize the joint, which potentially increases the stiffness. Although a cause is not usually reported, the physician obtains a general health history and a thorough history of recent and prior illness, surgery, and traumatic injury.

Physical exam: Pain during range of motion may be the only physical finding. Passive and active glenohumeral motions are decreased, often accompanied by pain and associated muscle spasms. Usually moving the arm away from the body (abduction) and outward (external) rotation are most severely affected. Motion between the scapula and the chest wall (scapulothoracic motion) is not affected by this condition. Diagnostic criteria include loss of 30° of external rotation and less than 130° of flexion (both actively and passively). Tenderness that is often generalized rather than localized usually is noted about the rotator cuff. Physical examination may include assessment of signs of illness or injury.

Tests: The diagnosis is often made through history and physical exam alone. Plain x-rays of the shoulder may be taken initially to rule out fracture, arthritis, tumor, or calcium deposits in the rotator cuff tendons. However, in primary adhesive capsulitis, x-rays usually are normal and are not definitive for diagnosis of the condition. X-rays of the cervical spine and/or electromyography (EMG) may be needed to evaluate neurological function, especially if a nerve problem in the neck is suspected as a cause of the shoulder pain and stiffness. Diagnostic blood tests may be ordered to identify possible underlying illness such as diabetes, thyroid disease, hyperlipidemia, infection, or an inflammatory condition such as rheumatoid arthritis. If the diagnosis is in doubt, or there is lack of progress after approximately 3 months of treatment, more sophisticated testing may be performed. For example, an arthrogram may demonstrate diminished shoulder capsule volume, a bone scan increased uptake, and an MRI scan increased blood flow.

Source: Medical Disability Advisor



Treatment


Treatment for adhesive capsulitis usually is nonoperative (conservative) and begins with education regarding the condition. Nonsteroidal anti-inflammatory drugs (NSAIDs) often are helpful for relief of pain and inflammation. Narcotic analgesics may be used for individuals intolerant of NSAIDs and for those with severe pain. However, the mainstay of treatment is physical therapy, initiated promptly upon diagnosis, focusing on stretching and then strengthening exercises. The exercises are initially supervised by a physical therapist but later can be performed on a self-directed basis with periodic therapist and/or physician monitoring. Modalities such as ice, heat, and ultrasound also may be used to relieve pain. If pain limits participation in therapy, a combination of local anesthetic and a corticosteroid drug can be injected into the shoulder joint. In such a combination, the anesthetic provides short-term pain relief, while the corticosteroid provides longer-term reduction of inflammation and associated discomfort, ideally permitting more aggressive therapy. If injections are used, it may be advisable to use a relatively large volume in order to distend the contracted shoulder capsule. Suprascapular nerve block sometimes may be employed, injecting bupivacaine into the supraspinous fossa. This is a simple, steroid-free procedure with no notable complications except tenderness at the injection site (Roy). Use of slings or other types of immobilization is typically avoided.

If the individual is unable to regain motion after approximately 6 to 12 weeks of therapy, manipulation of the joint under general or regional anesthesia may be beneficial.

Adhesive capsulitis also can be treated surgically by cutting the capsule (capsular release). This is most commonly done using an arthroscope, although arthroscopy is difficult in adhesive capsulitis due to the contracted capsule and small joint volume. Open capsular release also can be performed, although this is rarely indicated since the natural history of adhesive capsulitis is one of progressive improvement. Individuals with diabetes often do not benefit from manipulation and more commonly require surgery if therapy fails.

Source: Medical Disability Advisor



Prognosis


Adhesive capsulitis is self-limiting, and most individuals recover with time and conservative treatment within 1 to 2 years. However, during this time, affected individuals can be significantly limited in shoulder activities. About 60% of individuals are left with some permanent loss of shoulder motion (Roy). Individuals with diabetes are particularly predisposed to slow and incomplete recovery.

Source: Medical Disability Advisor



Rehabilitation


Note on research and authorship

The rehabilitation for adhesive capsulitis of the shoulder will vary depending on the phase at which the patient presents for treatment. However, treatment involves active exercise in all three phases.

Phase 1: (lasting up to 9 months) - Rehabilitation for adhesive capsulitis of the shoulder must include patient education to prevent loss of motion, avoid painful movements and instruct in a home exercise program (Hannafin). Treatment should consist of passive and active assisted range of motion shoulder exercises. Pendulum and gentle closed chain stabilization exercises may be beneficial (Hannafin). Joint mobilization may be used to augment passive range of motion. Focus should be on reducing pain and preventing loss of motion.

Phase 2: (lasting up to 12 months) - Continue with treatment as in Phase 1. Active exercises may be added. As pain diminishes, active assisted and passive exercises may become more aggressive. Treatment must emphasize pain management, regaining motion and exercises that promote normal glenohumeral motions (Hannafin).

Phase 3: (lasting up to 2 years) - More aggressive treatment is recommended and can be tolerated by the patient during this phase of recovery. Rehabilitation must focus on regaining motion and strengthening the shoulder girdle and scapula musculature. Continue to emphasize exercises that promote normal glenohumeral movement (Hannafin).

Past research does not support the benefit of ultrasound, electrical stimulation (Van Der Heijden), heat, ice or iontophoresis for the treatment of adhesive capsulitis. Modalities may be beneficial for palliative relief of symptoms. Home exercise programs are critical, must be performed daily and should reflect the exercise regimen prescribed during rehabilitation (Hannafin). Intra-articular corticosteroid injections combined with physical therapy have been shown to be beneficial for the short term; however the effect was not well maintained over a 12 month period (Buchbinder; Carette).

Residual pain / limitations: Although a large degree of variability is discussed in the literature, up to 40% of those with adhesive capsulitis report resumed normal function despite some residual pain or limitations of movement (Griggs).

FREQUENCY OF REHABILITATION VISITS
Nonsurgical
SpecialistAdhesive Capsulitis of Shoulder
Physical or Occupational TherapistUp to 48 visits within 52 weeks; up to 18 for following 18 weeks; up to 6 for following 24 weeks
The table above represents a range of the usual acceptable number of visits for uncomplicated cases. It provides a framework based on the duration of tissue healing time and standard clinical practice.

Source: Medical Disability Advisor



Complications


Pain may persist and dysfunction of the upper extremity may result in permanent disability. Disuse may cause increased stiffness and loss of bone (osteoporosis) about the shoulder. The weaker bones, especially proximal humerus, may fracture should the individual fall or undergo manipulation under anesthesia. Surgical treatment such as arthroscopy or manipulation, particularly if aggressive, can result in more complications than conservative treatment, and thus prolonging recovery.

Source: Medical Disability Advisor



Return to Work (Restrictions / Accommodations)


Limitations in lifting, carrying, and reaching overhead depend on the type, frequency, and strength of shoulder motion required and the degree of pain the individual experiences. Arm function can be classified as restricted or absent when individuals exhibit very limited shoulder motion; however, individuals usually retain use of the hand. Individuals performing repetitive motion with the upper extremity are encouraged to maintain good posture during work and the work area must be ergonomically appropriate to prevent recurrence of FS. Individuals whose jobs involve performing heavy manual labor, who operate equipment that causes upper body vibrations, and those who must repeatedly lift heavy objects overhead may need to be permanently reassigned to other tasks.

Early in treatment, time must be allowed for multiple physical therapy sessions weekly. Individuals often need breaks during the workday to perform range of motion exercises, and require access to ice packs after exercising. Occasionally, pain medications or muscle relaxants may be prescribed to be taken during work hours. Company policy on medication usage should be reviewed to determine if pain medication use is compatible with job safety and function.

Source: Medical Disability Advisor



Failure to Recover


If an individual fails to recover within the expected maximum duration period, the reader may wish to consider the following questions to better understand the specifics of an individual's medical case.

Regarding diagnosis:

  • Was diagnosis of adhesive capsulitis confirmed?
  • Did x-rays reveal any bony abnormalities?
  • Was shoulder arthrogram or MRI done?
  • Were comorbid conditions identified that could account for delayed recovery?
  • Was a complete neurological exam done?

Regarding treatment:

  • Was physical therapy prescribed to address function, not just to relieve pain?
  • Did individual actively participate in and complete the recommended course of therapy?
  • Did individual improve or worsen during physical therapy?
  • Would individual benefit from additional therapy or a change in therapy?
  • Has individual's need to continue self-directed therapy been accommodated at work?
  • Has he or she been compliant with the treatment plan including recommended activity restrictions?
  • Are comorbid conditions also being addressed in overall treatment plan?
  • If a surgical procedure was required, were there any resulting complications?
  • If recovery from this procedure is not progressing as expected, are there extenuating circumstances?

Regarding prognosis:

  • How long after symptom onset was treatment sought?
  • Did individual receive adequate education in prevention of future overuse problems?
  • Can employer adequately accommodate work restrictions or provide reassignment to lighter tasks?

Source: Medical Disability Advisor



Cited References


Buchbinder, R., S. Green, and J. M. Youd. "Corticosteroid Injections for Shoulder Pain." Cochrane Database System Review 1 (2003): CD004016. National Center for Biotechnology Information. National Library of Medicine. 21 Oct. 2008 <PMID: 12535501>.

Carette, S., et al. "Intraarticular Corticosteroids, Supervised Physiotherapy, or a Combination of the Two in the Treatment of Adhesive Capsulitis of the Shoulder: A Placebo-Controlled Trial." Arthritis and Rheumatism 48 3 (2003): 829-838. National Center for Biotechnology Information. National Library of Medicine. 21 Oct. 2008 <PMID: 12632439>.

Griggs, S. M., A. Ahn, and A. Green. "Idiopathic Adhesive Capsulitis. A Prospective Functional Outcome Study of Nonoperative Treatment." Journal of Bone and Joint Surgery 82-A 10 (2000): 1398-1407. National Center for Biotechnology Information. National Library of Medicine. 21 Oct. 2008 <PMID: 11057467>.

Hannafin, J. A., and T. A. Chiaia. "Adhesive Capsulitis. A Treatment Approach." Clinical Orthopaedics and Related Research 372 (2000): 95-109. National Center for Biotechnology Information. National Library of Medicine. 21 Oct. 2008 <PMID: 10738419>.

Roy, Andre, et al. "Adhesive Capsulitis." eMedicine. Eds. Curtis W. Slipman, et al. 12 Oct. 2007. Medscape. 19 Mar. 2008 <http://emedicine.medscape.com/article/326828-overview>.

Van Der Heijden, G. L., et al. "No Effect of Bipolar Interferential Electrotherapy and Pulsed Ultrasound for Soft Tissue Shoulder Disorders: A Randomized Controlled Trial." Annals of the Rheumatic Diseases. 530-540. National Center for Biotechnology Information. 58 National Library of Medicine. 21 Oct. 2008 <PMID: 10460185>.

Source: Medical Disability Advisor






Feedback
Send us comments, suggestions, corrections, or anything you would like us to hear. If you are not logged in, you must include your email address, in order for us to respond. We cannot, unfortunately, respond to every comment. If you are seeking medical advice, please contact your physician. Thank you!
Send this comment to:
Sales Customer Support Content Development
 
This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is published with the understanding that the author, editors, and publisher are not engaged in rendering medical, legal, accounting or other professional service. If medical, legal, or other expert assistance is required, the service of a competent professional should be sought. We are unable to respond to requests for advice. Any Sales inquiries should include an email address or other means of communication.